GeneralConnection.com ➔ Dictionary
Dictionary Search

myelofibrosis

Synonyms

Noun

1. fibrosis

Usage
INCA033989 Shows Potential as a Targeted Approach for Myelofibrosis With Mutant Calreticulin: Claire Harrison, MD - Journal of Managed Care
A Transformative Study for an Unmet Clinical Need: Myelofibrosis - Fox Chase Cancer Center
Rovadicitinib, a first-in-class JAK/ROCK inhibitor, in patients with myelofibrosis: a preclinical and phase I study - nature.com
Management of splenomegaly in patients with myelofibrosis in the era of JAK inhibitors: a comprehensive review - Frontiers
Dr Harrison on Implications of the INDEPENDENCE Data for Luspatercept in Myelofibrosis-Associated Anemia - OncLive
When Should You Employ Transplantation in Myelofibrosis Therapy? - CancerNetwork
Phase 3 SENTRY Trial Shows Progress in Myelofibrosis Care - Cure Today
Imetelstat Demonstrates Survival Benefit in R/R Myelofibrosis Vs Real-World Data - Oncology Nursing News
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction - Karyopharm
Latest Advancements in Myelofibrosis Treatment: Key Updates from EHA and ASH 2025 - European Medical Journal
Early Results Demonstrate Safety and Efficacy of Mutant Calreticulin–Specific Monoclonal Antibody in Myelofibrosis - The ASCO Post
Myelofibrosis: Facts and Statistics: What You Need to Know - Verywell Health
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review - Haematologica
Evolving Strategies for Myelofibrosis-Associated Anemia Highlight Persistent Gaps in Biomarker Guidance - OncLive
Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome - nature.com
Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026 - Karyopharm
Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis - CancerNetwork
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis - OncLive
Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial - nature.com
Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images | Leukemia - nature.com
An Educational Overview of Newly Diagnosed Stage 1 Myelofibrosis - Cure Today
Dr Hunter on Luspatercept and Other Treatment Options for Anemia in Myelofibrosis - OncLive
FDA Clears Protocol Update for Tasquinimod in Myelofibrosis Trial - Cure Today
INCA033989 Is Safe and Produces Spleen, Symptom, Anemia, and Molecular Responses in CALR-Mutated Myelofibrosis - OncLive
Imetelstat Sustains Significant Survival Benefit in R/R Myelofibrosis - Targeted Oncology
Early Data Show INCA033989 Activity in Calreticulin-Driven Myelofibrosis - Cure Today
SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD - Journal of Managed Care
FDA Approves Once-Daily Jakafi XR for Myelofibrosis and Other Conditions - Cure Today
Selinexor and Ruxolitinib Combo Shows Promise for Myelofibrosis - Oncology News Central
Retrospective Data Highlight Challenges, Potential Therapeutic Strategies With Allo-HSCT in Myelofibrosis and BP-MPNs - OncLive
DISC-0974 Produces Meaningful Hematologic Responses in Myelofibrosis-Associated Anemia - Targeted Oncology
In Intermediate-Risk Myelofibrosis, Experts Focus on Symptom Relief - Targeted Oncology
Inflammatory mediators differentially regulate megakaryopoiesis and thrombopoiesis in myelofibrosis and essential thrombocythemia - nature.com
Ipsen pens $1.7B deal to acquire Kartos for potential Jakafi add-on therapy for myelofibrosis - Fierce Biotech
Dr Kuykendall on Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosis - OncLive
Karyopharm myeloma drug yields mixed data in myelofibrosis trial - BioPharma Dive
Momelotinib May Not Be Cost-Effective Intervention for Myelofibrosis or Anemia - Hematology Advisor
New Treg Therapy Earns FDA Orphan Drug Designation in Myelofibrosis - CancerNetwork
How Selinexor Plus Ruxolitinib Could Affect Frontline Myelofibrosis Management - OncLive
Myelofibrosis (MF) in 2026: Matching Therapy to the Dominant Clinical Problem - Oncodaily
Scientists Uncover New Treatment for Bone Marrow Cancer - MetroHealth
FDA Orphan Drug Designation Granted to Zavabresib for Myelofibrosis - Cure Today
Dual Antibodies Beat Single for Type 1 CALR-Mutant Myelofibrosis - Targeted Oncology
PIM-1 Inhibition Offers a Novel Approach in Myelofibrosis - Targeted Oncology
Selinexor Plus Ruxolitinib Hits SVR Primary End Point in Myelofibrosis - OncLive
Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation - Karyopharm
NFκB/IL-6/JAK2/STAT axis in myelofibrosis is a key vulnerability that is targetable and relevant to JAK2 inhibitor treatment resistance | Blood Cancer Journal - nature.com
Nuvisertib Combo Improves Safety in JAK-Pretreated R/R Myelofibrosis - CancerNetwork
FDA Approves Ruxolitinib Extended-Release Tablets for Myelofibrosis, Polycythemia Vera, and GVHD - Docwire News
Sequential treatment with ruxolitinib and imetelstat effectively depletes myelofibrosis hematopoietic stem and progenitor cells | Leukemia - nature.com
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on ‘real world’ experience of JAK inhibitors, splenomegaly management and novel agents in the tra - nature.com
Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026 - Pharmacy Times – Pharmacy Practice News and Expert Insights
'Provocative' Survival Result in Myelofibrosis Trial - MedPage Today
Reassessing the Prognostic Weight of Anemia Plus Thrombocytopenia in Primary Myelofibrosis - Pharmacy Times – Pharmacy Practice News and Expert Insights
Treatment-relevant misdiagnosis of autoimmune myelofibrosis - Haematologica
Selinexor Combo Hits Spleen Target, Misses Symptom Endpoint in Myelofibrosis - Medical Professionals Reference
AJ1-11095 Receives Orphan Drug Designation From the FDA in Myelofibrosis - OncLive
Karyopharm’s Phase III myelofibrosis trial delivers mixed results - Clinical Trials Arena
FDA Grants Orphan Drug Designation to CK0804 for Myelofibrosis - Cure Today
RALLY-MF: Anti-Hemojuvelin Antibody DISC-0974 Yields Hematologic Responses in Patients With Anemia and Myelofibrosis - ASCO Daily News
Key Findings to Watch in SENTRY Trial of Selinexor/Ruxolitinib in Myelofibrosis - OncLive
Long-Term Consequences of Myelofibrosis and the Impact of Early Intervention - Pharmacy Times – Pharmacy Practice News and Expert Insights
Peri-Transplant Ruxolitinib Leads to Low GVHD Incidence in Myelofibrosis - OncLive
Machine learning identifies inflammation-related diagnostic biomarkers for primary myelofibrosis with clinical validation - nature.com
Selinexor Plus Ruxolitinib Improves Spleen Responses, Shows OS Signal in Frontline Myelofibrosis - Targeted Oncology
Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution - Cureus
Cutaneous Extramedullary Hematopoiesis in Primary Myelofibrosis: A Case Report With Rapidly Fatal Outcome - Cureus
Navigating the Expanding Landscape of Myelofibrosis Treatment - Pharmacy Times – Pharmacy Practice News and Expert Insights
Zavabresib Granted Orphan Drug Designation for Myelofibrosis - Targeted Oncology
Zavabresib Nets FDA Orphan Drug Designation for Myelofibrosis - OncLive
The SENTRY Trial: Selinexor Plus Ruxolitinib in JAK Inhibitor–Naive Myelofibrosis - OncLive
Vonjo Improves Blood Counts in Patients With Myelofibrosis and Anemia - Cure Today
Anemia Management in Myelofibrosis: Survival and Quality of Life - Cure Today
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis - OncLive
JAK Inhibitors Persist, While Novel Agents Aim for Disease Modification in Myelofibrosis - OncLive
POIESIS Trial Evaluates Navtemadlin/Ruxolitinib Combo in Myelofibrosis - Oncology Nursing News
FDA-Approved JAK Inhibitors in Myelofibrosis: Mechanisms, Indications, and Clinical Impact - Pharmacy Times – Pharmacy Practice News and Expert Insights
Lexington woman seeks stem cell donors for rare bone marrow cancer - WKYT
Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis - Karyopharm
Selective BET Inhibition With ABBV-744 Shows Early Clinical Activity in Myelofibrosis - Pharmacy Times – Pharmacy Practice News and Expert Insights
Early Data for Tagraxofusp Support Further Evaluation in Combination Therapies in Myelofibrosis - OncLive
FDA Clears Once-Daily Ruxolitinib Tablets for Myelofibrosis, Polycythemia Vera, and GVHD - OncLive
Understanding Myelofibrosis: What It Is, Who Is at Risk, and How It’s Treated - Future of Personal Health -
Tagraxofusp Shows Manageable Safety Profile, Modest Activity as Monotherapy in Myelofibrosis - Pharmacy Times – Pharmacy Practice News and Expert Insights
Jakafi Trial Shows Benefits for Patients with Myelofibrosis and Anemia - Cure Today
Understanding Current Treatment for Myelofibrosis - Cure Today
Dr Jain on Treatment Decision-Making With JAK Inhibitors in Myelofibrosis - OncLive
Dr Gerds on the Importance of Disease-Modifying Therapies in Myelofibrosis - OncLive
Dr Gerds on the Differences Between Available JAK Inhibitors for Myelofibrosis - OncLive
Understanding Myelofibrosis and the Central Role of JAK Pathway Dysregulation - Pharmacy Times – Pharmacy Practice News and Expert Insights
CK0804 Receives FDA Orphan Drug Designation for Myelofibrosis - OncLive
Ultraprecision Targeting of CALR Mutations Signals a New Era in Myelofibrosis Treatment - Pharmacy Times – Pharmacy Practice News and Expert Insights
Second Harmonic Generation-Based Collagen Analysis and Automated Grading of Myelofibrosis - Wiley Online Library
Evaluating the Current Myelofibrosis Treatment Paradigm - CancerNetwork
Karyopharm Slides as Mixed Myelofibrosis Results Cloud Regulatory Road - BioSpace
Dr Kuykendall on the Relevance of QOL End Points in Myelofibrosis Clinical Trials - OncLive
Managing and Understanding Toxicities Associated With Myelofibrosis Therapy - CancerNetwork
Long-Term Jakafi (Ruxolitinib) Use Linked to Improved Daily Life in Myelofibrosis - news.cancerconnect.com
Dr Mascarenhas on the Role of Imetelstat in the Myelofibrosis Treatment Paradigm - OncLive
Dr Jain on the Role of Ruxolitinib in Polycythemia Vera and Myelofibrosis - OncLive
Foreign Language Equivalents
Foreign Language Equivalents of 'myelofibrosis'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
myelofobrosis,   melofibrosis,   meylofibrosis,   myelfibrosis,   myeelofibrosis,   myelofbirosis,   yelofibrosis,   myelofiborsis,   myeolfibrosis,   myelofibrrosis,   myelfoibrosis,   myelofubrosis,   myelofibrisis,   myelofbrosis,   myelofibrosiss,   myelofibrosi,   nyelofibrosis,   myeloofibrosis,   myelofibbrosis,   myelofibosis,   mmyelofibrosis,   myelofibroosis,   myelofiibrosis,   mye;ofibrosis,   myelofibrossi,   myelofibrosos,   myyelofibrosis,   myleofibrosis,   myeofibrosis,   myrlofibrosis,   myelofibrodis,   muelofibrosis,   mtelofibrosis,   myelofibrosiis,   myekofibrosis,   ,yelofibrosis,   myelofibrosid,   myelpfibrosis,   myelofibroais,   myelofibrpsis,   myelogibrosis,   myelofivrosis,   myelifibrosis,   myelofibross,   myelofirosis,   myelofirbosis,   myelofibrsois,   mylofibrosis,   mywlofibrosis,   myelofibroiss,   myeloibrosis,   myelofibrosus,   myelofibrossis,   myelofibrosia,   myelofibrois,   myelofibrsis,   myellofibrosis,   myelofibtosis,   myelofibeosis,   ymelofibrosis,   myelofinrosis,   myeloifbrosis,   myelodibrosis,   myeloffibrosis
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z